Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypereosinophilia”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Not applicableLooking for participantsNCT00001406
What this trial is testing

Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia

Who this might be right for
Immune System DiseasesEosinophiliaHelminthiasis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 800
Testing effectiveness (Phase 2)Study completedNCT00787384
What this trial is testing

Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes

Who this might be right for
Hypereosinophilic SyndromeChronic Eosinophilic LeukemiaChronic Idiopathic Hypereosinophilia
Northern Italy Leukemia Group 25
Large-scale testing (Phase 3)Looking for participantsNCT06512883
What this trial is testing

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

Who this might be right for
Eosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilia Syndrome (HES)
AstraZeneca 14
Large-scale testing (Phase 3)Study completedNCT00086658
What this trial is testing

Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)

Who this might be right for
HypereosinophiliaHypereosinophilic Syndrome
GlaxoSmithKline 86
Large-scale testing (Phase 3)UnknownNCT02130882
What this trial is testing

Study to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic Syndrome

Who this might be right for
Respiratory System AgentsAnti-Asthmatic AgentsHematologic Diseases+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 20
Testing effectiveness (Phase 2)UnknownNCT00276926
What this trial is testing

Study of STI571 in the Treatment of Patients With Idiopathic Hypereosinophilic Syndrome (HES) and Eosinophilic Leukemias

Who this might be right for
Hypereosinophilic SyndromeChronic Eosinophilic Leukemia (CEL)Myeloproliferative Disorders
University of Bologna
Not applicableLooking for participantsNCT04018118
What this trial is testing

Natural History of Hypereosinophilia and Hypereosinophilic Syndromes

Who this might be right for
EosinophiliaHypereosinophilic Syndrome
University Hospital, Lille 600
Testing effectiveness (Phase 2)Study completedNCT00017862
What this trial is testing

Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome

Who this might be right for
Hypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 10
Post-approval studies (Phase 4)Study completedNCT01524536
What this trial is testing

Steroid Treatment for Hypereosinophilic Syndrome

Who this might be right for
EosinophiliaHypereosinophilic SyndromeLeukocyte Disorder+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 26
Not applicableUnknownNCT03378882
What this trial is testing

Research for Angiostrongylus Cantonensis and Costaricensis in French West Indies and French Guiana

Who this might be right for
AngiostrongylosisHypereosinophilia
University Hospital Center of Martinique 20
Large-scale testing (Phase 3)Ended earlyNCT00097370
What this trial is testing

Open-Label Extension Of Intravenous Mepolizumab In Patients With Hypereosinophilic Syndrome

Who this might be right for
Hypereosinophilic Syndrome
GlaxoSmithKline 78
Not applicableLooking for participantsNCT00091871
What this trial is testing

A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Who this might be right for
EosinophiliaHypereosinophilic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 50